ProCE Banner Series

Pneumococcal Disease Prevention: Integrating the Latest Vaccine Updates Into Practice

Join our expert faculty at this live symposium as they discuss key data from ASHP 2024 and provide insights and recommendations on optimizing pneumococcal vaccines in adult and pediatric populations.  

A symposium conducted at the 2024 ASHP Midyear Clinical Meeting & Exhibition.

  ACPE-P
  | ACPE-T
Who Should Attend

This program is intended for community and clinical pharmacists, pharmacy technicians, and other healthcare professionals involved in recommending or providing pneumococcal vaccine services for pediatric and/or adult populations.

All Events

Pneumococcal Disease Prevention: Integrating the Latest Vaccine Updates Into Practice

Upcoming Events

December

10

2024

11:00 AM - 1:00 PM Central Time (CT)

In-person

New Orleans Ernest N. Morial Convention Center, 900 Convention Center Blvd, New Orleans, Louisiana 70240

11:30 AM - 1:00 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
International Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

ProCE Banner Faculty
Richard H. Dang, PharmD, APh

Assistant Professor of Clinical Pharmacy
Assistant Director of the Residency Programs
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Los Angeles, California

ProCE Banner Faculty
Jeff Goad, PharmD, MPH, FAPhA, FASHP, FISTM

Professor of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, California

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Vaccination.

Target Audience
This program is intended for community and clinical pharmacists, pharmacy technicians, and other healthcare professionals involved in recommending or providing pneumococcal vaccine services for pediatric and/or adult populations.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Summarize prominent pneumococcal serotypes causing disease and severity in pediatric and adult populations

  • Update pediatric and adult pneumococcal vaccine strategies based on the latest developments, scientific data, and recommendations

  • Provide strong pneumococcal vaccine recommendations for adult candidates that promote acceptance in candidate populations with suboptimal uptake rates

Accreditation

Pharmacists and Pharmacy Technicians

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-24-009-L06-P/T has been assigned to this live application activity (initial release date 12/10/24). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure of Conflicts of Interest
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE, LLC policy. ProCE, LLC is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by ProCE, LLC

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.